We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Technology Networks Explores the CRISPR Revolution – Coming Soon
Industry Insight

Through a series of exclusive interviews with world-renowned scientists and bioethicists, Technology Networks Explores the CRISPR Revolution will investigate the ground-breaking research taking place in the CRISPR space, CRISPR "controversies" and whether the CRISPR technology looks set to fulfil its promise of revolutionizing science.

Read More

10 Things to Note About Manufacturing Viral Vectors
Industry Insight

10 things to note about viral vector manufacturing, regarding the complexities and challenges, and the technology that will help drive cell and gene therapy forward. Here we share insights from Pall and Molmed representatives, who are leaders in the fields of bioprocessing and cell and gene therapy.

Read More

Harnessing the Power of Proteins To Unlock Cell and Gene Therapies
Industry Insight

We recently spoke with Paul Wotton, Ph.D., CEO at Obsidian Therapeutics, to gain his insights on the genetically engineered cell-therapy research area, and to learn how Obsidian Therapeutics' cytoDRiVE platform can increases the specificity and safety of such therapies.

Read More

Developing Novel Therapies for the Treatment of Respiratory Diseases
Industry Insight

We recently had the pleasure of speaking with Martin Gosling, Enterprise Therapeutics’ CSO and Professor of Molecular Pharmacology at the University of Sussex. Martin highlights the respiratory diseases Enterprise Therapeutics primarily focus on and the new disease modifying therapies they have in development.

Read More

Enabling Accurate One-step DNA Assembly
Industry Insight

Long sequences of DNA are a key requirement for researchers to be able to develop novel synthetic biomolecules. However, assembling long sequences can prove problematic and slow down the process of gene assembly. GenBrick™ utilizes a novel proprietary technology to enable accurate one-step DNA assembly. We spoke with Cedric Wu, Ph.D., GenScript Sr. Director of R&D to learn more about the capabilities of GenBrick™.

Read More

Talking NGS, Liquid Biopsies and Tumor Mutational Burden With Luca Quagliata
Industry Insight

We recently spoke with Luca Quagliata, Ph.D., Global Director of Medical Affairs for Thermo Fisher Scientific. Previously, Quagliata was involved in one of the first teams in Europe to introduce Next Generation Sequencing (NGS) in routine molecular diagnostics. Here, he shares his perspectives on the field, particularly the use of NGS in the analysis of liquid biopsies, the discovery of cancer biomarkers and the potential application of artificial intelligence (AI) in molecular diagnostics.

Read More

Single Cell Analysis – Advantages, Challenges, and Applications
Industry Insight

We recently spoke with Dr Marian Rehak, VP of Research and Development at Sphere Fluidics, to learn more about the importance of single cell analysis. Marian touches on some of the common challenges encountered and highlights some of the key applications.

Read More

NRGene Are Taking Agricultural Research to the MAX
Industry Insight

NRGene recently announced the launch of DeNovoMAX, an enhanced version of its flagship product DeNovoMAGIC, for whole genome assembly. As part of the DeNovo assembly product suite, DeNovoMAX aims to take agricultural research further by empowering breeding and maximizing agricultural yield. We spoke with Gal Ramot, Marketing Director at NRGene Ltd to learn about the applications of DeNovoMAX and how it has been built to crack the most "complex of genomes".

Read More

Wellness and Illness From a Precision Quantification Perspective
Industry Insight

In this interview, Aaron Hudson, Vice President & General Manager, Global Marketing & Strategy at SCIEX, discusses why precision quantification, specifically quantitative mass spectrometry (MS), is the best approach for measuring the transition from "wellness" to illness.

Read More

DNA and RNA: Why It’s All About Integrity
Industry Insight

In this interview, we spoke with Knut Wintergerst, PhD, General Manager of Biomolecular Systems and Solutions (BSS) and Diagnostics and Genomics Group (DGG) at Agilent to learn more about why DNA and RNA sample integrity is important to scientists and how it can be maintained and analyzed.

Read More

 
Advertisement